<DOC>
	<DOCNO>NCT01545557</DOCNO>
	<brief_summary>The aim study assess performance tolerance well investigator subject satisfaction pan-facial volume restoration new cross-linked hyaluronic acid dermal filler contain lidocaine 0.3 % .</brief_summary>
	<brief_title>Pan Facial Volume Restoration</brief_title>
	<detailed_description>Clinical hypothesis : The global approach subject pan-facial dermal volume depletion face soft-tissue contour defect correction use specific dermal filler indication inject satisfy subject investigator . This device use full face correction volume loss : chin , temporal area , jawline , cheek , cheekbone , deep deep nasolabial fold ( cheekbone inject concomitantly ) . Study duration 19 month . Injections perform baseline . If necessary , investigator perform touch-up injection follow visit ( 3 week baseline injection ) .</detailed_description>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Subjects seek treatment correction volume loss . Subjects present score 2 ( visible depression descent ) whole face volume loss scale least 2 indication affected volume loss among follow : chin temporal area , jawlines , cheek , cheekbone , deep deep nasolabial fold ( severity score 4 least Lemperle rating scale ) cheekbone inject . Subjects risk term precaution , warning contraindication refer package insert study device , Subjects undergo previous injection permanent filler injected area .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Volume loss</keyword>
</DOC>